CP-060S interacts with three principal binding sites on the L-type Ca 2+ channel

By Suzuki Y.   Tamura K.   Adachi Y.   Fukazawa M.   Kato T.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 347-351

Elsevier

Access to resources Recommend Favorite

Effects of CP-060S, a Novel Cardioprotective Drug, on Cardiac Function and Myocardial Oxygen Consumption - a new cytoprotective principle

By Momber A.W.   Mohan R.S.   Kovacevic R.   Suzuki Y.   Akima M.   Tamura K.  

General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. : 57-63

Elsevier

Access to resources Recommend Favorite

Antiarrhythmic and cardiohemodynamic effects of a novel Ca 2+ channel blocker, AH-1058, assessed in canine arrhythmia models

By Takahara A.   Sugiyama A.   Dohmoto H.   Yoshimoto R.   Hashimoto K.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 107-112

Elsevier

Access to resources Recommend Favorite

Effects of a novel, potent benzothiazepine Ca 2+ channel antagonist, DTZ323, on guinea-pig ventricular myocytes

By Kurokawa J.   Adachi-Akahane S.   Nagao T.  

European Journal of Pharmacology, Vol. 325, Iss. 2, 1997-05 ,pp. : 229-236

Elsevier

Access to resources Recommend Favorite

Actions of CP-060S on veratridine-induced Ca 2+ overload in cardiomyocytes and mechanical activities in vascular strips

By Tamura K.   Suzuki Y.   Koga T.   Akima M.   Kato T.   Nabata H.  

European Journal of Pharmacology, Vol. 312, Iss. 2, 1996-09 ,pp. : 195-202

Elsevier

Access to resources Recommend Favorite